AC Immune SA (ACIU) stock
ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.10−0.01 (-0.47%)
Close on Nov 18, 2026Market cap $213.66MP/E –Yield –
AC Immune revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
AC Immune's revenue for the twelve months ending Dec 31, 2022 was CHF 3.94M. For fiscal 2025 it was CHF 3.57M, down 86.9% from the year before. Over ten years it grew -21.3% a year on average. The highest annual figure on record is CHF 110.46M in fiscal 2019.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CHF 3.57M | -86.9% |
| FY2024 | Dec 31, 2024 | CHF 27.31M | +84.5% |
| FY2023 | Dec 31, 2023 | CHF 14.80M | +276.1% |
| FY2022 | Dec 31, 2022 | CHF 3.94M | – |
| FY2021 | Dec 31, 2021 | CHF 0 | -100.0% |
| FY2020 | Dec 31, 2020 | CHF 15.43M | -86.0% |
| FY2019 | Dec 31, 2019 | CHF 110.46M | +1498.0% |
| FY2018 | Dec 31, 2018 | CHF 6.91M | -65.9% |
| FY2017 | Dec 31, 2017 | CHF 20.26M | -12.7% |
| FY2016 | Dec 31, 2016 | CHF 23.21M | -40.6% |
| FY2015 | Dec 31, 2015 | CHF 39.09M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | CHF 1.31M | -66.8% |
| Q2 FY2024 | Jun 30, 2024 | CHF 687.00K | – |
| Q2 FY2023 | Jun 30, 2023 | CHF 0 | – |
| Q4 FY2022 | Dec 31, 2022 | CHF 1.00K | – |
| Q3 FY2022 | Sep 30, 2022 | CHF 3.93M | +180.4% |
| Q2 FY2022 | Jun 30, 2022 | CHF 0 | -100.0% |
| Q4 FY2021 | Dec 31, 2021 | CHF 0 | -100.0% |
| Q3 FY2021 | Sep 30, 2021 | CHF 0 | -100.0% |
| Q4 FY2018 | Dec 31, 2018 | CHF 1.40M | -91.5% |
| Q3 FY2018 | Sep 30, 2018 | CHF 2.31M | +114.6% |
| Q2 FY2018 | Jun 30, 2018 | CHF 2.03M | +169.3% |
| Q1 FY2018 | Mar 31, 2018 | CHF 1.46M | -27.3% |
| Q4 FY2017 | Dec 31, 2017 | CHF 16.42M | – |
| Q3 FY2017 | Sep 30, 2017 | CHF 1.07M | – |
| Q2 FY2017 | Jun 30, 2017 | CHF 753.00K | – |
| Q1 FY2017 | Mar 31, 2017 | CHF 2.01M | – |
See a number that looks wrong?